NCT00684528
A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin
Phase: Phase 3
Role: Collaborator
Start: Jun 30, 2008
Completion: Dec 31, 2012